Menopause Test Kits Market
Menopause Test Kits Market

Report ID: SQMIG35J2862

[email protected]
USA +1 351-333-4748

Menopause Test Kits Market Size, Share, and Growth Analysis

Menopause Test Kits Market

Menopause Test Kits Market By Test Type (FSH-Based Test Kits, Multi-Hormone Test Kits, Other Menopause-Related Test Kits), By Testing Method (Urine-Based Tests, Blood-Based Tests, Other Testing Methods), By Distribution Channel, By End User, By Region - Industry Forecast 2026-2033


Report ID: SQMIG35J2862 | Region: Global | Published Date: November, 2026
Pages: 157 |Tables: 118 |Figures: 77

Format - word format excel data power point presentation

Menopause Test Kits Market Insights

Global Menopause Test Kits Market size was valued at USD 620.0 Million in 2024 and is poised to grow from USD 659.68 Million in 2025 to USD 1083.6 Million by 2033, growing at a CAGR of 6.4% during the forecast period (2026-2033).

The global menopause test‑kit market comprises diagnostic assays that quantify hormone levels such as estradiol, FSH, and AMH to confirm a woman’s menopausal status. Its importance stems from the growing need to distinguish natural menopause from endocrine disorders, enabling targeted therapy and avoiding unnecessary prescriptions. The primary driver is expanding awareness among women aged 45‑60 of the health implications of hormonal shifts, fueled by health‑information campaigns and social‑media advocacy. Historically, diagnosis required costly laboratory visits; over the past decade inexpensive point‑of‑care kits have entered pharmacies, exemplified by Everlywell’s Menopause Hormone Test in 2019. This shift reflects demand for convenient diagnostics. Building on heightened awareness, integration of menopause test kits with digital health platforms drives significant growth. A user collects a saliva sample, uploads the result to an app, and a clinician reviews hormone levels, schedules a teleconsultation, and recommends lifestyle changes, shortening the diagnostic timeline. This loop has sparked partnerships such as Ro’s alliance with a clinic to bundle testing with quarterly hormone‑management visits. Expanded insurance coverage for remote diagnostics lowers cost barriers, and rising disposable income in markets fuels adoption. As a result, the sector expects a double‑digit CAGR, with data‑rich, personalized solutions becoming routine in women’s preventive care.

How is AI enhancing diagnostic accuracy in the menopause test kits market?

AI is raising diagnostic accuracy in menopause test kits by turning raw hormone data into clear health insights. Machine learning models compare hormone patterns with large clinical databases, spotting subtle shifts that traditional labs may miss. This creates personalized reports that link hormone levels to symptom profiles, helping users and clinicians make informed decisions. The market now sees more consumers choosing convenient at home testing, driven by confidence in digital interpretation. Companies integrate AI into mobile apps, delivering results quickly and reducing the need for repeat sampling. As awareness of menopause health grows, AI backed kits are becoming a trusted part of preventive care.Everlywell August 2023, introduced an AI driven algorithm that interprets hormone levels with greater nuance, reducing false positives and aligning results with individual symptom narratives. This advancement shortens the time to actionable insight and encourages broader adoption of at home menopause testing, fueling market momentum.

Market snapshot - (2026-2033)

Global Market Size

USD 620.0 Million

Largest Segment

Multi-Hormone Test Kits

Fastest Growth

Multi-Hormone Test Kits

Growth Rate

6.4% CAGR

Menopause Test Kits Market ($ Mn)
Country Share for North America Region (%)

To get more insights on this market click here to Request a Free Sample Report

Menopause Test Kits Market Segments Analysis

Global menopause test kits market is segmented by test type, testing method, distribution channel, end user and region. Based on test type, the market is segmented into FSH-Based Test Kits, Multi-Hormone Test Kits and Other Menopause-Related Test Kits. Based on testing method, the market is segmented into Urine-Based Tests, Blood-Based Tests and Other Testing Methods. Based on distribution channel, the market is segmented into Retail Pharmacies & Drugstores, Online Retail, Hospitals & Clinics and Diagnostic Laboratories. Based on end user, the market is segmented into Home Users, Healthcare Providers and Diagnostic Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

What role do multi‑hormone test kits play in transforming the menopause test kits market?

Multi‑Hormone Test Kits segment dominates because it captures comprehensive hormonal profiles, enabling clinicians and women to pinpoint menopausal transition with greater confidence. The breadth of markers reduces the need for multiple separate assays, creating a streamlined workflow that resonates with both healthcare providers and self testing consumers. Its ability to address a wider symptom spectrum drives preference, fostering brand loyalty and reinforcing its central role in market adoption.

Meanwhile, Other Menopause Related Test Kits emerge as the fastest growing because they target niche concerns such as bone density and cardiovascular risk, aligning with evolving wellness trends. Innovative point of care formats and lifestyle brand partnerships accelerate consumer awareness, expanding market footprint. Their specialized focus creates new revenue streams and fuels broader acceptance of menopause testing.

how is online retail shaping access to menopause test kits?

Online Retail segment dominates because it offers unparalleled convenience, allowing women to discreetly order kits from home and receive results digitally. The ease of access reduces barriers associated with pharmacy visits, while extensive e commerce platforms provide rich product information that guides purchasing decisions. Seamless integration with telehealth services further amplifies its appeal, cementing online channels as the primary growth driver. Additionally, targeted digital marketing leverages data analytics to personalize offers, reinforcing customer loyalty and repeat purchases.

Conversely, Hospitals & Clinics segment is witnessing the strongest growth as providers integrate menopause test kits into routine gynecological assessments. Institutional adoption is propelled by clinical guidelines that endorse hormone profiling for personalized care. Investment in in house laboratory capabilities and referral networks expands test utilization, creating a robust channel that fuels market expansion and enhances patient management pathways.

Menopause Test Kits Market By Test Type

To get detailed segments analysis, Request a Free Sample Report

Menopause Test Kits Market Regional Insights

Why does North America Dominate the Global Menopause Test Kits Market?

North America leads the menopause test kits market through a combination of advanced healthcare infrastructure, strong consumer awareness, and robust research ecosystems. The region benefits from widespread acceptance of preventive health practices and a high degree of physician engagement in menopause management. Market participants find supportive regulatory environments that accelerate product introductions, while reimbursement frameworks in key markets enable broader patient access. The presence of leading diagnostic manufacturers and well‑established distribution channels further fortifies market reach. Together, these factors create a fertile environment for innovation and sustained demand, solidifying North America’s position as the dominant market.

United States Menopause Test Kits Market

Menopause Test Kits Market in the United States is driven by a mature consumer health culture that embraces personalized diagnostics. Extensive insurance coverage and strong clinician endorsement promote adoption, while a competitive landscape of biotech firms accelerates product diversity. Educational initiatives raise awareness of menopause symptoms, encouraging women to seek timely testing. The integration of digital health platforms enhances accessibility, supporting a broad and engaged user base.

Canada Menopause Test Kits Market

Menopause Test Kits Market in Canada benefits from a publicly funded healthcare system that facilitates equitable access to diagnostic services. Provincial health agencies prioritize women's health initiatives, fostering awareness and encouraging routine testing. Collaboration between research institutions and commercial laboratories drives innovation, while telehealth solutions expand reach into remote communities. Consumer confidence in evidence‑based testing, coupled with supportive policy frameworks, sustains steady demand across the Canadian market.

What is Driving the Rapid Expansion of Menopause Test Kits Market in Europe?

Europe experiences rapid expansion of menopause test kits driven by strong public health commitments and a collaborative regulatory landscape that encourages cross‑border product availability. Integrated healthcare systems place emphasis on preventive care for women, leading to heightened clinician recommendation and patient acceptance. Growing consumer interest in personalized health insights fuels demand, while academic research hubs contribute to continuous innovation. Market entry is further supported by harmonized standards that simplify certification processes across member states. Together, these dynamics nurture a fertile market environment, positioning Europe as a burgeoning hub for menopause diagnostics.

Germany Menopause Test Kits Market

Menopause Test Kits Market in Germany is anchored by a comprehensive health insurance framework that reimburses diagnostic procedures, encouraging widespread uptake. Strong collaboration between research universities and industry accelerates development of advanced testing technologies. Public health campaigns raise awareness about menopause health, prompting proactive testing among women. Integration of digital health records facilitates seamless data sharing, enhancing clinical decision‑making and reinforcing market growth.

United Kingdom Menopause Test Kits Market

Menopause Test Kits Market in the United Kingdom benefits from a proactive public health agenda that emphasizes early detection and patient empowerment. National health guidelines endorse routine menopause screening, driving clinician adoption. A vibrant biotech sector introduces innovative testing solutions, while consumer‑focused wellness platforms increase accessibility. Telemedicine services expand reach to underserved areas, supporting broad participation and reinforcing the market’s rapid expansion.

France Menopause Test Kits Market

Menopause Test Kits Market in France is emerging through targeted health initiatives that spotlight women's well‑being during midlife transitions. Governmental support for preventive health programs encourages testing adoption, while partnerships with academic institutions foster research advancements. Growing consumer interest in personalized health monitoring spurs demand for accessible diagnostic kits. Digital health applications streamline appointment scheduling and result delivery, contributing to a steadily expanding market presence.

How is Asia Pacific Strengthening its Position in Menopause Test Kits Market?

Asia Pacific is strengthening its position in the menopause test kits market by leveraging rising health consciousness and rapid digital adoption across the region. Growing middle‑class populations increasingly prioritize preventive care, creating demand for accessible diagnostic solutions. Regional regulatory bodies are evolving to support innovative health technologies, facilitating smoother market entry for new products. Collaborative initiatives between local manufacturers and multinational firms accelerate technology transfer and product localization. Additionally, expanding telehealth infrastructure enhances reach into remote areas, ensuring broader coverage and fostering a supportive ecosystem for menopause diagnostics.

Japan Menopause Test Kits Market

Menopause Test Kits Market in Japan is propelled by a culturally ingrained focus on preventive health and an aging female demographic that values early detection. Strong government health policies endorse regular screening, while advanced medical technology providers introduce sophisticated testing options. Integration of mobile health applications simplifies user engagement and result interpretation, enhancing accessibility for women across urban and rural settings.

South Korea Menopause Test Kits Market

Menopause Test Kits Market in South Korea benefits from a technologically adept population that embraces digital health solutions. National health programs promote awareness of menopausal health, encouraging routine testing. Collaborative research between universities and biotech companies drives innovation in non‑invasive testing methods. The proliferation of e‑commerce platforms facilitates convenient distribution, expanding market penetration and reinforcing South Korea’s growing role in the region.

Menopause Test Kits Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Menopause Test Kits Market Dynamics

Drivers

Increasing Awareness of Menopause Health

  • The growing public discourse on menopause, amplified by media campaigns and patient advocacy groups, raises women’s confidence in recognizing symptoms and seeking objective measures. As awareness translates into proactive health management, more individuals turn to convenient at‑home test kits to monitor hormonal changes. This behavioral shift expands the potential consumer base, encourages repeat usage for longitudinal tracking, and stimulates interest from retailers and distributors. The perception that early detection can improve quality of life further motivates purchase decisions, sustaining market expansion.

Healthcare Providers adopting Remote Testing

  • Healthcare providers are increasingly integrating remote testing protocols into routine menopausal care, recognizing the convenience and timeliness of at‑home hormone assessments. By recommending kits during telehealth consultations, clinicians expand diagnostic reach to patients who might avoid clinic visits. This adoption strengthens physician confidence in self‑collected samples, encourages broader patient participation, and creates a feedback loop that validates kit accuracy through clinical oversight. Consequently, provider endorsement elevates product credibility, drives higher prescription‑like uptake, and fuels sustained market growth in the evolving healthcare landscape.

Restraints

Regulatory Uncertainty Around Diagnostic Claims

  • Regulatory uncertainty surrounding the classification of menopause test kits creates a barrier for manufacturers seeking clear approval pathways. Ambiguities regarding whether kits are regulated as medical devices, in‑vitro diagnostics, or wellness products lead to prolonged submission processes and variable compliance requirements across regions. This unpredictability discourages investment in product innovation, delays market entry, and compels companies to allocate resources to extensive legal scrutiny rather than research. As a result, the pace of new product introductions slows, limiting the overall expansion of the market.

Limited Insurance Reimbursement for Home Kits

  • Limited insurance reimbursement for at‑home menopause test kits restricts affordability for many potential users, especially those without supplemental private coverage. When insurers deem kits as non‑essential or classify them under elective wellness services, out‑of‑pocket costs remain high, deterring regular adoption. This financial barrier reduces overall market penetration, confining sales primarily to self‑pay segments. Consequently, manufacturers face constrained demand signals, which may limit economies of scale and inhibit broader distribution strategies, thereby tempering market growth prospects. The resulting limited uptake also hampers data collection for broader clinical validation.

Request Free Customization of this report to help us to meet your business objectives.

Menopause Test Kits Market Competitive Landscape

The competitive landscape of the global menopause test kits market is shaped by intense rivalry among established diagnostics firms and emerging biotech innovators, driving rapid product differentiation and strategic collaborations. Recent M&A activity, such as the acquisition of a niche hormone assay developer by a major laboratory group, and partnerships between test kit manufacturers and digital health platforms, illustrate how companies are leveraging technology integration and distribution networks to capture market share.

Top Player’s Company Profile

  • Abbott Laboratories
  • QuidelOrtho Corporation
  • Church & Dwight Co., Inc.
  • Procter & Gamble Company
  • Hologic, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • bioMérieux SA
  • Mankind Pharma Limited
  • Wondfo Biotech Co., Ltd.
  • Sugentech, Inc.
  • Geratherm Medical AG
  • Everlywell, Inc.
  • LetsGetChecked
  • Modern Fertility
  • Clearblue
  • First Response
  • NOVA Biomedical
  • Medline Industries, LP
  • EKF Diagnostics Holdings plc

Recent Developments

  • Abbott Laboratories launched the Abbott Menopause Insight Kit in September 2025, a fully automated home test that simultaneously measures estradiol, FSH and LH from a finger‑prick sample. The kit integrates a smartphone app for result interpretation and provides personalized health guidance, expanding Abbott’s at‑home diagnostic portfolio and addressing unmet consumer demand.
  • Roche Diagnostics announced a strategic partnership with Siemens Healthineers in June 2025 to co‑develop a next‑generation lab‑based menopause hormone panel leveraging Roche’s immunoassay technology on Siemens’ high‑throughput analyzers. This collaboration aims to deliver faster, more precise hormone profiling for clinicians managing menopausal care and to support integrated electronic health record reporting, enhancing workflow efficiency across hospitals and specialty clinics.
  • Wondfo Biotech Co., Ltd. introduced a low‑cost rapid menopause test strip in March 2025, enabling point‑of‑care measurement of follicle‑stimulating hormone using a lateral flow format. The product targets emerging markets, offering results within five minutes and supporting broader access to menopause diagnostics in community health settings and facilitating early intervention for women experiencing symptomatic transitions.

Menopause Test Kits Key Market Trends

Menopause Test Kits Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, the global menopause test kits market is being propelled primarily by rising awareness of menopause health, which encourages women to seek at‑home hormone assessments, while a second strong catalyst comes from healthcare providers integrating remote testing into routine care, boosting clinician endorsement and repeat use. The market is led by North America, where advanced infrastructure and supportive reimbursement accelerate adoption, and the Multi‑Hormone Test Kits segment captures the largest share thanks to its comprehensive hormonal profiling. Digital health platforms further enable quick result interpretation, reinforcing consumer confidence. However, regulatory uncertainty around diagnostic claims hampers rapid product launches and may slow overall growth.

Report Metric Details
Market size value in 2024 USD 620.0 Million
Market size value in 2033 USD 1083.6 Million
Growth Rate 6.4%
Base year 2024
Forecast period (2026-2033)
Forecast Unit (Value) USD Million
Segments covered
  • Test Type
    • FSH-Based Test Kits
    • Multi-Hormone Test Kits
    • Other Menopause-Related Test Kits
  • Testing Method
    • Urine-Based Tests
    • Blood-Based Tests
    • Other Testing Methods
  • Distribution Channel
    • Retail Pharmacies & Drugstores
    • Online Retail
    • Hospitals & Clinics
    • Diagnostic Laboratories
  • End User
    • Home Users
    • Healthcare Providers
    • Diagnostic Laboratories
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Abbott Laboratories
  • QuidelOrtho Corporation
  • Church & Dwight Co., Inc.
  • Procter & Gamble Company
  • Hologic, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • bioMérieux SA
  • Mankind Pharma Limited
  • Wondfo Biotech Co., Ltd.
  • Sugentech, Inc.
  • Geratherm Medical AG
  • Everlywell, Inc.
  • LetsGetChecked
  • Modern Fertility
  • Clearblue
  • First Response
  • NOVA Biomedical
  • Medline Industries, LP
  • EKF Diagnostics Holdings plc
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Menopause Test Kits Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Menopause Test Kits Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Menopause Test Kits Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Menopause Test Kits Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Menopause Test Kits Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Menopause Test Kits Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300

REQUEST FOR SAMPLE

Please verify that you're not a robot to proceed!
Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Menopause Test Kits Market size was valued at USD 620.0 Million in 2024 and is poised to grow from USD 659.68 Million in 2025 to USD 1083.6 Million by 2033, growing at a CAGR of 6.4% during the forecast period (2026-2033).

The competitive landscape of the global menopause test kits market is shaped by intense rivalry among established diagnostics firms and emerging biotech innovators, driving rapid product differentiation and strategic collaborations. Recent M&A activity, such as the acquisition of a niche hormone assay developer by a major laboratory group, and partnerships between test kit manufacturers and digital health platforms, illustrate how companies are leveraging technology integration and distribution networks to capture market share. 'Abbott Laboratories', 'QuidelOrtho Corporation', 'Church & Dwight Co., Inc.', 'Procter & Gamble Company', 'Hologic, Inc.', 'F. Hoffmann-La Roche Ltd.', 'Siemens Healthineers AG', 'bioMérieux SA', 'Mankind Pharma Limited', 'Wondfo Biotech Co., Ltd.', 'Sugentech, Inc.', 'Geratherm Medical AG', 'Everlywell, Inc.', 'LetsGetChecked', 'Modern Fertility', 'Clearblue', 'First Response', 'NOVA Biomedical', 'Medline Industries, LP', 'EKF Diagnostics Holdings plc'

The growing public discourse on menopause, amplified by media campaigns and patient advocacy groups, raises women’s confidence in recognizing symptoms and seeking objective measures. As awareness translates into proactive health management, more individuals turn to convenient at‑home test kits to monitor hormonal changes. This behavioral shift expands the potential consumer base, encourages repeat usage for longitudinal tracking, and stimulates interest from retailers and distributors. The perception that early detection can improve quality of life further motivates purchase decisions, sustaining market expansion.

Personalized Hormone Monitoring: Consumers are increasingly seeking test kits that deliver individualized hormone profiles, moving beyond generic estradiol or FSH readings. Companies are incorporating genomics and lifestyle data to tailor recommendations, enabling women to monitor symptom trajectories and adjust interventions proactively. This shift is driven by heightened health awareness, digital health integration, and the desire for empowerment in managing perimenopause. As a result, product roadmaps prioritize modular assay panels and adaptive analytics, positioning kits as holistic wellness tools rather than single-parameter diagnostics solutions.

Why does North America Dominate the Global Menopause Test Kits Market? |@12
AGC3x.webp
Aisin3x.webp
ASKA P Co. LTD3x.webp
BD3x.webp
BILL & MELIDA3x.webp
BOSCH3x.webp
CHUNGHWA TELECOM3x.webp
DAIKIN3x.webp
DEPARTMENT OF SCIENCE & TECHNOLOGY3x.webp
ETRI3x.webp
Fiti Testing3x.webp
GERRESHEIMER3x.webp
HENKEL3x.webp
HITACHI3x.webp
HOLISTIC MEDICAL CENTRE3x.webp
Institute for information industry3x.webp
JAXA3x.webp
JTI3x.webp
Khidi3x.webp
METHOD.3x.webp
Missul E&S3x.webp
MITSUBISHI3x.webp
MIZUHO3x.webp
NEC3x.webp
Nippon steel3x.webp
NOVARTIS3x.webp
Nttdata3x.webp
OSSTEM3x.webp
PALL3x.webp
Panasonic3x.webp
RECKITT3x.webp
Rohm3x.webp
RR KABEL3x.webp
SAMSUNG ELECTRONICS3x.webp
SEKISUI3x.webp
Sensata3x.webp
SENSEAIR3x.webp
Soft Bank Group3x.webp
SYSMEX3x.webp
TERUMO3x.webp
TOYOTA3x.webp
UNDP3x.webp
Unilever3x.webp
YAMAHA3x.webp
Yokogawa3x.webp

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Feedback From Our Clients